ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π² Π³Π΅ΡΠ΅ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΡΡ ΡΠΈΡΡΠ΅ΠΌΠ°Ρ Π³Π΅Π½ΠΎΠ² Ρ ΠΈΠΌΠ΅ΡΠ½ΡΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½ΠΎΠ² ΠΈ Π³Π΅Π½Π° Π±Π°ΡΡΡΠ°ΡΠ°
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ Π³Π΅Π½ΠΎΠ² Ρ ΠΈΠΌΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΌΡΡΡ/ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ IgE Π±ΡΠ» ΠΎΡΠ΅Π½Π΅Π½ ΡΡΠΎΠ²Π΅Π½Ρ Π±ΠΈΠΎΡΠΈΠ½ΡΠ΅Π·Π° ΡΠ΅Π»Π΅Π²ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ° in vivo Π² ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΡΠΊΠ°Π½ΡΡ ΠΌΡΡΠΈ: ΡΠ΅Π»Π΅Π·Π΅Π½ΠΊΠ΅ (ΠΈΠΌΠΌΡΠ½ΠΎΠΊΠΎΠΌΠΏΠ΅ΡΠ΅Π½ΡΠ½ΡΠΉ ΠΎΡΠ³Π°Π½), ΠΏΠ΅ΡΠ΅Π½ΠΈ (ΡΠ΅ΡΠ΅Π· ΠΏΠ΅ΡΠ΅Π½Ρ ΠΏΡΠΎΡ ΠΎΠ΄ΠΈΡ Π±ΠΎΠ»ΡΡΠΎΠΉ ΠΎΠ±ΡΠ΅ΠΌ ΠΊΡΠΎΠ²ΠΈ), ΠΏΠΎΠ΄ΡΡΠΊΠ°Ρ Π»Π°ΠΏ (Π½Π΅ ΡΡΠΎΠ»Ρ Ρ ΠΎΡΠΎΡΠΎ ΡΠ½Π°Π±ΠΆΠ°ΡΡΡΡ ΠΊΡΠΎΠ²ΡΡ) ΠΈ Ρ ΡΡΡΠ΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΡΡΠ΅ΠΉ (Π² Π»ΡΠ±ΠΎΠΉ Ρ ΡΡΡΠ΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠ»Π΅ΠΊΡΠ» ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ΅ΡΡΡ ΠΈΡΠΊΠ»ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Π·Π° ΡΡΠ΅Ρ Π΄ΠΈΡΡΡΠ·ΠΈΠΈ). Π’Π°ΠΊΠΆΠ΅ Π±ΡΠ»Π° Π΄Π°Π½Π°… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΏΠΈΡΠΎΠΊ ΠΎΠ±ΠΎΠ·Π½Π°ΡΠ΅Π½ΠΈΠΉ ΠΈ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠΉ Π·
- ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- 1. ΠΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½ Π ΠΊΠ°ΠΊ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠΉ Π°Π³Π΅Π½Ρ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ°
- 1. Π‘Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΎ ΡΡΠ½ΠΊΡΠΈΡΡ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° Π
- 2. ΠΠ½ΠΈΡΠΈΠ°ΡΠΈΡ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° Π
- 3. Π Π΅Π³ΡΠ»ΡΡΠΎΡΠ½ΡΠ΅ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° Π
- 4. ΠΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½ Π ΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ΅Π°ΠΊΡΠΈΡ ΠΊΠ°ΠΊ ΡΠ°ΠΊΡΠΎΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΈ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΎΡΡΠ° ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ
- 5. ΠΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½ΠΎΠ² Π² ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
- 2. ΠΠ΅Π½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ
- 1. ΠΠ±ΡΠ΅Π΅ ΠΎΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΡΠΈΠΏΠΎΠ² Π³Π΅Π½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ
- 2. ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π³Π΅Π½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ
- 3. Π₯ΠΈΠΌΠ΅ΡΠ½ΡΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΊΠ°ΠΊ ΡΡΡΠ΅ΠΊΡΠΎΡΠ½ΡΠΉ Π±Π΅Π»ΠΎΠΊ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
- 4. Π€Π°ΠΊΡΠΎΡΡ, ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°ΡΡΠΈΠ΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π³Π΅Π½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ
- 2. 4 1 ΠΠΎΡΡΠ°Π²ΠΊΠ° Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π°
- 2. 4 2 ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π³Π΅Π½ΠΎΠ²
- 3. ΠΠΊΡΠΏΠ΅ΡΠ΅ΡΡΠΈΡ Π³Π΅Π½ΠΎΠ² Π±Π°ΡΡΡΠ°ΡΠ° ΠΈ Ρ ΠΈΠΌΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° 38 Π Π΅Π·ΡΠΌΠ΅ ΠΎΠ±Π·ΠΎΡΠ° Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ
- Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅
- 1. Π‘ΠΎΠ·Π΄Π°Π½ΠΈΠ΅ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΈ ΠΈ Π°Π½Π°Π»ΠΈΠ· ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π³Π΅Π½Π° Π±Π°ΡΡΡΠ°ΡΠ° Π² ΡΠΈΠ±ΡΠΎΠ±Π»Π°ΡΡΠ°Ρ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΈ Π² ΡΠΌΠ±ΡΠΈΠΎΠ½Π΅ ΠΌΡΡΠΈ
- 2. ΠΠ°Π»Π»ΠΈΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΠ°Π½ΡΡΠ΅ΠΊΡΠΈΡ
- 3. ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π³Π΅Π½ΠΎΠ² Ρ ΠΈΠΌΠ΅ΡΠ½ΠΎΠ³ΠΎΠ Π² ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΡΠΊΠ°Π½ΡΡ ΠΈ ΠΎΡΠ³Π°Π½Π°Ρ ΠΌΡΡΠ΅ΠΉ, ΠΈΠΌΠΌΡΠ½Π½ΡΠΉ ΠΎΡΠ²Π΅Ρ Π½Π° ΠΊΡΠ΅Π½ΠΎΠ³Π΅Π½Π½ΡΠ΅ Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°Π½ΡΡ
- 4. ΠΡΠ²ΠΎΠ΄ ΡΠΎΡΠΌΡΠ»Ρ ΠΏΠΎΠ΄ΡΡΠ΅ΡΠ° ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ Ρ ΠΈΠΌΠ΅ΡΠ½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ°
- 5. ΠΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Ρ ΠΈΠΌΠ΅ΡΠ½ΠΎΠ³ΠΎΠ ΠΈ ΠΈΠΌΠΌΡΠ½Π½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° Π½Π° ΠΊΡΠ΅Π½ΠΎΠ³Π΅Π½Π½ΡΠ΅ Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°Π½ΡΡ
- Π²ΡΠ²ΠΎΠ΄Ρ
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ½ΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΠΎΠ²Π°ΡΡ ΠΠΎΠ΄ ΡΠ΅Π΄ ΠΠ‘ ΠΠΈΠ»ΡΡΠΎΠ²Π° Π: «Π‘ΠΎΠ²Π΅ΡΡΠΊΠ°Ρ ΠΠΊΡΠΈΠΊΠ»ΠΎΠΏΠ΅Π΄ΠΈΡ», 1989
- Sutton Π.J., Gould H.J. The human IgE network, Nature, 1999, V.366, p.421−428
- Vernersson M. The rise and fall of IgE, Uppsala University, 2002
- Chang T.W. Developing antibodies for targeting immunoglobulin and membrane-bound immunoglobulin E, Allergy Asthma Proc, 2006, V.27, #2 (Suppl 1): 7−14
- Blank U., Jouvin M.H., Guerin-Marchand C., Kinet J.P. The high-affinity IgE receptor: lessons from structural analysis, Med Sci, 2003, V.19, #1, p. 63−9
- Roitt I., Essential Immunology, 6th edition, 1997
- Mills PK, Beeson WL, Fraser GE, Philips RL Allergy and cancer: organ site-specific results from Adventist health study Am. J. Epidemiol. 1992 136: 287−295
- Szczeklik A, Jawien J, Stadler BM, Radwan J, Piwowarska W, Dziatkowiak A Possible relationship between IL-6 and response of IgE to surgical trauma Ann. NY Acad. Sci. 1995 762:477−479
- Szczeklik A., Jawien J. IgE in acute phase response to surgical stress, Clin Exp Allergy, 1996, V.26, p.303−307lO.Szczeklik A., Jawien J. Possible role of IgE in acute-phase response, Allergy, 1997, V.52, p. l 149−1150
- Kapmen G.T., Poulsen L.K., Nielsen H.J., Schulze S., Petersen L.J. IgE levels in surgery: effect of ranitidine and prednisolone, Allergy, 1999, V.54, p. l 71−176
- Navarro-Zorraquino M., Lozano R., Deus J., Pastor C., Larrad L., Tejero E., Roman J., Palacios M.J., Torcal J., Salinas J.C. Determination of the IgE postoperative variation as a measure of surgical injury, World J Surg, 2001, V.25, p.585−591
- Smith J.K., Krishnaswamy G.H., Dykes R., Reynolds S., Berk S.L. Clinical manifestations of IgE hypogammaglobulinemia, Ann Allergy Asthma Immunol, 1997, V.78, p.313−318
- Schoettler J.J., Schleissner L.A., Heiner D.C. Familial IgE deficiency associated with sinopulmonary disease, Chest, 1989, V.96, p.516−521
- Levy D.A., Chen J. Healthy IgE-deficient person, N Engl J Med, 1970, V.283, p.541
- Wesrman S., Gustavsson S., Heyman B. Early explanation of secondary B cells after primary immunization with antigen complexed with IgE, Scand J Immunol, 1997, V.46, p. 10−15
- Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors, Annu Rev Immunol, 2000, V.18, p.709−737
- Gould H., Br Med Bui, 2000, V.56, p.908−924
- Nowak-Wegrzyn A., Sampson H.A. Food allergy therapy, Immunol Allergy Clin North Am, 2004, V.24, #4, p.705−725
- Oettgen H.S., Geha R.S. IgE regulation and roles in asthma pathogenesis, J Allergy Clin Immunol, 2001, V.107, #3, p.429−441
- Yamaguchi M., Sayama K., Yano K., Lantz C., Noben-Trauth N. et al J Immunol, 1999, V.162, #9, p.5455−5465
- Mills P.K., Beeson W.L., Fraser G.E., Phillips R.L. Allergy and cancer: organ site-specific results from the Adventist Health Study, Am J Epidemiol, 1992, V.136, #3, p.287−295
- Gould H.J., Sutton B.J., Beavil A.J., Beavil R.L., McCloskey N., Coker H.A., Fear D., Smurthwaite L. The biology of IGE and the basis of allergic disease, Annu Rev Im, 2003, V.21, p.579−628
- Fisherman E.W. Does the allergic diathesis influence malignancy?, J Allergy, 1960, V.31, p.74−78
- Mackay W.D. The incidence of allergic disorder and cancer, Br J Cancer, 1966, V.20, p.434−437
- Ure D.M.J. Negative association between allergy and cancer, Scot Med J, 1969, V.14, p.51−54
- McK.ee W.D., Arnold C.A., Perlman M.D. A double-blind study of the comparative incidence of malignancy and allergy, J Allergy, 1967, V.39, p.294−301
- Meers P.D., Allergy and Cancer, Lancet, 1973, V. l, p.884−885
- Vena J.E., Bona J.R., Byers T.E., Middleton E. Jr, Swanson M.K., Graham S. Allergy-related diseases and cancer: an inverse association, Am J Epidemiol, 1985, V.122, #1, p.66−74
- Wang H., Rothenbacher D., Low M., Stegmaier C., Brenner H., Diepgen T.L. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum, Int J Cancer, 2006, V. l 19, #3, p.695−701
- Gould H.J., Mackay G.A., Karagiannis S.N., O’Toole C.M., Marsh P.J., Daniel B.E., Coney L.R., Zurawski V.R. Jr., Joseph M., Capron M., Gilbert
- M., Murphy G.F., Korngold R. Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma, Eur J Immunol, 1999, V.29, #11, p.3527−3537
- Nagy E., Berczi I., Sehon A.H. Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus, Cancer Immunol Immunother, 1991, V.34, p.63−69
- MacGlashan D.W.Jr, Mckenzie-White J., Chichester K., Bochner B.S., Davis F.M., Schroeder J.T., Lichtenstein L.M. In vitro regulation of FcsRIa expression on human basophils by IgE antibody, Blood, 1988, V.91, p. 16 331 634
- Gould H.J., Mackay G.A. et a! Eur J Imm, 1999, V.29, p.3527−3537
- ΠΠ°ΡΠ°Π½ΠΎΠ² B.C. «Π‘ΠΎΡΠΎΡΠΎΠ²ΡΠΊΠΈΠΉ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΡΠΉ ΠΆΡΡΠ½Π°Π»», 1999, № 3, Ρ. 1−640.3Π΅Π»Π΅Π½ΠΈΠ½ Π.Π., ΠΠ°ΠΉΠ³ΠΎΡΠΎΠ΄ΠΎΠ² Π. Π., ΠΡΠ°ΡΠΎΠ»ΠΎΠ² B.C. ΠΠ΅Π½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ ΡΠ΅Π³ΠΎΠ΄Π½Ρ ΠΈΠ·Π°Π²ΡΡΠ°, ΠΠΎΠ» Π±ΠΈΠΎΠ», 1998, Π’.32, № 2, Ρ.219−228
- Culver K.W. Gene therapy: a handbook for physicians, 1994
- Molecular and Cell Biology of Human Gene Therapeutics, 1995
- Gura T. Science, 1995, V.270, p.575−577
- Siatskas C., Chan J., Field J., Murphy K., Nasa Z., Toh B.H., Alderuccio F. Gene therapy strategies towards immune tolerance to treat the autoimmune diseases, Curr Gene Ther, 2006, V.6, #1, p.45−58
- Dzau V.J. Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010?, Am J Cardiol, 2003, V.92, p.32−35
- LI S., Tokuyama T., Yamamoto J., Koide M., Yokota N., Namba H. Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene, Oncology, 2005, V.69, #6, p.503−508
- Muller F.J., Snyder E.Y., Loring J.F. Gene therapy: can neural stem cells deliver?, Nat Rev Neurosci, 2006, V.7, #1, p.75−84
- Yates F., Daley G.Q. Progress and prospects: gene transfer into embryonic stem cells, Gene Ther, 2006, V.13, #20, p.1431−1439
- Kay M.A., Liu D., Hoogerbrugge P.M. Gene therapy, Proc Natl Acad Sci USA, 1997, V.94, #24, p.12 744−12 746
- Roberts J.P. Transcription controls segmentation clock gene, Scientist, 2002, V.16, #20, p.45
- Smith K.T., Shepherd A.J., Boyd J.E., Lees J.M., Gene Delivery Systems for Use in Gene Therapy: An Overview of Quality Assurance and Safety Issues, Gene Therapy, 1996, V.3, p. 190−200
- Expert Reviews in Molecular Medicine, 1999, Cambridge University Press
- Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-Xl disease, Blood, 2000, V.96, p.590
- Rosen F.S. Successful Gene Therapy for Severe Combined Immunodeficiency The New England Journal of Medicine, 2002, V.346, #16, p.1241−1243
- Wade N, Patient Dies While Undergoing Gene Therapy, The New York Times, 1999, September 29
- Koehler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 1975, V.256, p.493−497
- Jones P.T., Deat P.H., Foote J. Neuberger M.S., Winter G. Nature, 1986, V.321, p.522−525 b
- Gura S. Therapeutic antibodies: Magic bullets hit the target, Nature, 2002, V.417, p.584 586
- Wolff J. A., Malone R. W., Williams P., Chong W., AcSadi G., Jani A., Felgner P. L. Direct Gene Transfer into Mouse Muscle in Vivo, Science, 1990, V.247, #4949, p.1465−1468
- Schreurs M.W., de Boer A.J., Figdor C.G., Adema G.J., Genetic vaccination against the melanocyte lineage-specific antigen gplOO induces cytotoxic T lymphocyte-mediated tumor protection, Cancer Res, 1998, V.58, #12, p.2509−2514
- Taubes G. Science 1997 05 Dec V.278, 1711−1714
- Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus, Nat Med, 1995, V. l, #6, p.583−587
- Johnston S.A., Barry M.A. Vaccine, 1997, V.15, #8, p.808−809
- Schuler K., Lu C., Chang H.D., Croft M., Zanetti M., Gerloni M.
- Circumvention of MHC class II restriction by genetic immunization, Vaccine, 2001, V.20, #3−4, p.630−634
- Π€Π°Π²ΠΎΡΠΎΠ²Π° O.O. Π‘ΠΎΡΠΎΡΠΎΠ²ΡΠΊΠΈΠΉ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΡΠΉ ΠΆΡΡΠ½Π°Π», 1997, № 2, Ρ.21−27
- Culver K.W. Gene therapy: a handbook for physicians, NY: May Ann Liebert Inc Publ, 1994, p. l 17
- Marr R.A., Hitt M., Muller W.J., Gauldie J., Graham F.L. Int J Oncol, 1998, V.12, #3, p.509−515
- ΠΠ΅ΡΠΈΠ½ΡΠΊΠ°Ρ Π.Π. Π‘ΠΎΡΠΎΡΠΎΠ²ΡΠΊΠΈΠΉ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΡΠΉ ΠΆΡΡΠ½Π°Π», 1996, № 1, Ρ.32−39
- Weisz Π., David A.L., Gregory L.G., Perocheau D., Ruthe A., Waddington S.N., Themis M., Cook Π’., Coutelle C., Rodeck C.H., Peebles D.M. Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for
- Duchenne muscular dystrophy, Am J Obstet Gynecol, 2005, V.193, #3, p. l 105−1109
- Chuah M.K., Collen D., VandenDriessche T. Clinical gene transfer studies for hemophilia A, Semin Thromb Hemost, 2004, V.30, #2, p.249−256
- Densmore C.L. Advances in noninvasive pulmonary gene therapy, Curr Drug Deliv, 2006, V.3, #1, p.55−63
- Koehler D.R., Martin Π., Corey M., Palmer D., Ng P., Tanswell A.K., Hu J. Readministration of helper-dependent adenovirus to mouse lung, Gene Ther, 2006, Jan 26 Epub ahead of print.
- Malik P., Arumugam P.I. Gene Therapy for {beta}-Thalassemia, Hematology (Am Soc Hematol Educ Program), 2005, p.45−50
- Bank A., Dorazio R., Leboulch P. A Phase I/II Clinical Trial of {beta}-Globin Gene Therapy for {beta}-Thalassemia, Ann NY Acad Sci, 2005, V.1054, p.308−316
- ΠΠ³ΠΎΠ» Π.Π. Π‘ΠΎΡΠΎΡΠΎΠ²ΡΠΊΠΈΠΉ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΡΠΉ ΠΆΡΡΠ½Π°Π», 1997, № 4, Ρ. 11−16
- ΠΠ³ΠΎΠ» Π.Π. Π‘ΠΎΡΠΎΡΠΎΠ²ΡΠΊΠΈΠΉ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΡΠΉ ΠΆΡΡΠ½Π°Π» 1997, № 9, Ρ.27−31
- Tang D., DeVit Π., Johnston S.A. Nature, 1992, V.356, p. 152−154
- Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., Haynes J.R. Vaccine, 1995, V.13, p.1427−1430
- Barry M.A., Johnston S.A. Vaccine, 1997, V.15, p.788−791
- Yang N-S., Sun W.H., McCabe D. Mol Med Today, 1996, V., p.476−481
- Biewenga J.E., Destree O.H., Schrama L.H. J Neurosci Methods, 1997, V.71, p.67−75
- Mahvi D.M., Sondel P.M., Yang N.S., Albertini M.R., Schiller J.H., Hank J., Heiner J., Gan J., Swain W., Logrono R. Hum Gene Ther, 1997, V.8, p.875−891
- Mahvi D.M., Burkholder J.K., Turner J., Culp J., Malter J.S., Sondel P.M., Yang N.S. Hum Gene Ther, 1996, V.7, p. 1535−1543
- Chen S.Y., Bagley J., Marasco W.A. Hum Gene Ther, 1994, V.5, p.595−601
- ΠΠΎΠ»Π΅ΡΠ½ΠΈΠΊΠΎΠ² B.A., ΠΠ΅Π΅Π½ΠΈΠ½Π° Π. Π., Π‘Π΅ΠΌΠ΅Π½ΠΎΠ²Π° M.JI., Π¨Π°ΡΠ΅ΠΉ Π ., ΠΠ΅Π»Π΅Π½ΠΈΠ½ Π. Π. ΠΡΡΠ½ Π±ΠΈΠΎΠ» ΡΠ°Π·Π², 1995, Π’.6, Ρ.467−480
- Xiong S., Gerloni M., Zanetti M. Proc Natl Acad Sei USA, 1997, V.94, p.6352−6357
- Zelenin A.V., Kolesnikov V.A., Tarasenko O.A., Shafei R.A., Zelenina I.A., Mikhailov V.V. et al. FEBS Letters, 1997, V.414, p.319−322
- Conry R.M., LoBuglio A.F., Kantor J., Schlom J., Loechel F., Moore S.E., Sumerel L.A., Barlow D.L., Abrams S., Curiel D.T. Cancer Res, 1994, V.54,p.l 164−1168
- Davis H.L., Whalen R.G., Demeneix B.A. Hum Gene Ther, 1993, V.4, p.151−159
- Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A., Baird S.M., Rhodes G.H. Proc Natl Acad Sei USA, 1994, V.91, p.9519−9523
- Wang B., Ugen K., Srikantan V., Agadjanyan M., Dang K., Refaeli Y., Sato A., Boyer J., Williams W., Weiner D. Proc Natl Acad Sei USA, 1993, V.90,p.4156−4160
- Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., DeWitt C.M., Orme I.M., Baldwin S., D’Souza C., Drowart A., 1. zes E., Vandenbussche P., Van Vooren J-P., Liu M.A., Ulmer J.B. Nat Med, 1996, V.2, p.893−898
- Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D. Nat Med, 1996, V.2, p.888−892
- Sedegah M., Hedstrom R., Hobart P., Hoffman S. L, Proc Natl Acad Sci USA, 1994, V.91, p.9866−9870
- Doolan D.L., Sedegah M., Hedstrom R.C., Hobart P., Charoenvit Y., Hoffman S.L. J Exp Med, 1996, V.183, p. 1739−1746
- Xu D., Liew F.Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major, Immunology, 1995, V.84, #2, p.173−176
- Cooper M.J., Lippa M., Payne J.M., Hatzivassiliou G., Reifenberg E., Fayazi B., Perales J.C., Morrison L.J., Templeton D., Piekarz R.L., Tan J. Proc Natl Acad Sci USA, 1997, V.94, p.6450−6455
- Shiraishi M, Kusano T, Hara J, Hiroyasu S, Shao-ping M, Makino Y, Muto Y Adenovirus-mediated gene transfer using in-situ perfusion of the liver graft, Transpl Int, 1997, V.10, #3, p.202−206
- Newton D.L., Ryback S.M. Antibody targeted therapeutics for lymphoma: new focus on the CD22 antigen and RNA, Expert Opin Biol Ther, 2001, V. 1, #6, p.995−1003
- Glinka E.M., Edelweiss E.F., Sapozhnikov A.M., Deyev S.M. Gene 2005, in press
- SchreiberG., Buckle A.M., FershtA.R. Structure, 1994, V.2, #10, p.945−951
- Deyev S.M., Yazynin S.A., Kuznetsov D.A., Jukovich M., Hartley R.W. Ribonuclease-charged vector for facile direct cloning with positive selection, Mol Gen Genet, 1998, V.259, #4, p.379−382
- Jucovic M., Hartley R.W. Protein-protein interaction: a genetic selection for compensating mutations at the barnase-barstar interface, Proc Natl Acad Sci USA, 1996, V.93, #6, p.2343−2347
- Jucovic M., Hartley R.W. In vivo system for the detection of low level activity barnase mutants, Protein Eng, 1995, V.8, #5, p.497−499
- Kershaw M.H. et al Oncol Res, 1998, V.10, #3, 133−142
- Gould H.J., Mackay G.A. et al Eur J 1 mm, 1999, V.29, p.3527−3537
- Sutton B.J., Gould HJ. The human IgE network, Nature, 1999, V.366, p.421−428
- Reali E. et al Cancer Res, 2001, V.61, #14, p.5517−5522
- Gould H.J. et al Annu Rev Im, 2003, V.21, p. 579−628
- Kamiya T., Sugio S., Yamanouchi K., Kagitani Y. Secretion of active Fc fragments of immunoglobulin E directed by the yeast invertase signal sequence in mammalian cells, J Exp Med, 1996, V.180, #4, p.297−308
- Nechansky A., Ruf C., Pursch E., Wasserbauer E., Stampfli M.R., Pachlopnik J.M., Stadler B.M., Kricek F. Interaction of human IgE with Fc epsilon RI alpha exposes hidden epitopes on IgE, Int Arch Allergy Immunol, 1999, V.120, #4, p.295−302
- Π Π°Π΄ΡΠΊΠΎ Π.Π. ΠΠ²ΡΠΎΡΠ΅ΡΠ΅ΡΠ°Ρ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ Π½Π° ΡΠΎΠΈΡΠΊΠ°Π½ΠΈΠ΅ Π½Π°ΡΡΠ½ΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΊΠ°Π½Π΄. Π±ΠΈΠΎΠ». Π½Π°ΡΠΊ. Π.: ΠΠΠ, 1998
- ΠΡΠ°ΡΠΎΠ»ΠΎΠ² B.C., Π§ΡΠΌΠ°ΠΊΠΎΠ² Π. Π. ΠΠΎΠ» Π±ΠΈΠΎΠ», 1988, Π’.22, Ρ. 1678−1687
- Zelenin A.V., Alimov A.A., Titomirov A.V., Kazansky A.V., Gorodetsky S.I., Kolenikov V.A. FEBS Lett, 1991, V.280, p.94−96
- ΠΠΎΠ»Π΅ΡΠ½ΠΈΠΊΠΎΠ² Π.Π., ΠΠ΅Π»Π΅Π½ΠΈΠ½Π° Π. Π., Π‘Π΅ΠΌΠ΅Π½ΠΎΠ²Π° M.JI., Π¨Π°ΡΠ΅ΠΉ Π ., ΠΠ΅Π»Π΅Π½ΠΈΠ½ Π. Π. ΠΠ½ΡΠΎΠ³Π΅Π½Π΅Π·, 1995, Π’.26, Ρ.467−480
- ΠΡΡΡΠΈ Π., Π Π°ΠΉΠΊΡΠ½Π΄Π°Π»ΠΈΡ Π§. ΠΠ½ΡΠΈΡΠ΅Π»Π°. ΠΠ΅ΡΠΎΠ΄Ρ. ΠΠΎΠ΄ ΡΠ΅Π΄. Π.ΠΡΡΡΠΈ. Π: ΠΠΈΡ 1991 Ρ 73
- Barsky V., Perov A., Tokalov S., et al J Biomol Screen, 2002, V, 7, p.247−257
- Barry M.A., Johnston S.A. Biological features of genetic immunization, Vaccine, 1997, V.15, #8, p.788−791
- Yang N-S., Sun W.H., McCabe D. Mol Med Today, 1996, p.476−481
- Deyev S.M., Lieber A., Radko B.V., Polanovsky O.L. Appl Biochem Biotechnol, 1994, V.47, #2−3, p.143−155
- Biewenga J.E., Destree O.H., Schrama L.H. J Neurosci Methods, 1997, V.71, p.67−75
- ΠΠΎΠ»Π΅ΡΠ½ΠΈΠΊΠΎΠ² Π.Π., ΠΠ΅Π»Π΅Π½ΠΈΠ½Π° Π. Π., Π‘Π΅ΠΌΠ΅Π½ΠΎΠ²Π° Π. Π., Π¨Π°ΡΠ΅ΠΉ Π ., ΠΠ΅Π»Π΅Π½ΠΈΠ½ Π. Π. ΠΠ½ΡΠΎΠ³Π΅Π½Π΅Π·, 1995, Π’.6, Ρ.467−480
- Sundaram P., Xiao W., Brandsma K.L. Nucl Acids Research, 1996, V.24, p.1375−1377
- Yang N-S., Sun W.H., McCabe D. Mol Med Today, 1996, V. p.476−481
- Mahvi D.M., Sondel P.M., Yang N.S., Albertini M.R., Schiller J.H., Hank J., Heiner J., Gan J., Swain W., Logrono R. Hum Gene Ther, 1997, V.8, p.875−891
- Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., Haynes J.R. Vaccine, 1995, V.13, p. l427−1430